Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2003
09/25/2003WO2003078379A1 AMORPHOUS Hmg-CoA REDUCTASE INHIBITORS OF DESIRED PARTICLE SIZE
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077908A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003035059A3 Spermicides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181505 Novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)-1-methylethyl pentanoate
09/25/2003US20030181496 Having Transforming Growth Factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030180804 (Serine) protease modulators; membrane proteins
09/25/2003US20030180383 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
09/25/2003CA2479222A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1345934A2 Sulfonylpyrroles
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345896A1 Crystalline forms of atorvastatin
09/24/2003EP1345604A1 Antitumor therapy comprising distamycin derivatives
09/24/2003EP1036061B1 New compounds
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0946507B1 Substituted pyrrolyl compounds for the treatment of inflammation
09/24/2003EP0944598B1 Substituted benzamide derivatives and pharmaceutical compositions containing them
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1443757A Dipyrrolinone subunit compound, coloring agent containing said compound and its preparation method
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624314 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/23/2003US6624313 Treating the corrresponding 3-protected hydroxypyrrolidine compound with a base in the presence of an alkyl alcohol and isolating the crystalline form
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624303 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624120 Substituted herbicidal phenyluracils
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2227696C Process for synthesizing carbapenem side chain intermediates
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076478A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176713 Process for the production of sulfonic esters
09/18/2003US20030176712 Distilling in a distillation column a liquid, formed by adding to an odorous components-containing liquid having a N-vinyl-2-pyrrolidone purity lower than 90 wt.%, a compound with lower boiling point than N-vinyl-2-pyrrolidone
09/18/2003US20030176711 Process for the production of sulfonic esters
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176479 Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030172478 Bipyrrolinonylidene-type compound, colorant therewith, and method of producton thereof
09/18/2003US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/17/2003EP1344789A2 Thermosetting resin composition containing malemide and/or vinyl compounds
09/17/2003EP1344778A1 Bipyrrolinonylidene-type compound, its use as colorant, and method of production thereof
09/17/2003EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443180A Novel compounds having antiinflamatory activity process for their preparation and pharmaceutical compositions containing them
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620946 Include compounds having aromatic, rigid-rod like spacer groups between the crosslinkable groups, these compounds impart a liquid crystal-like character to the thermosetting resin composition which results low shrinkage upon cure
09/16/2003US6620945 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents
09/16/2003US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS)
09/16/2003US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/16/2003US6620823 Antiinflammatory agents; rheumatic disorders
09/16/2003CA2273253C Novel n-substituted pyrrolidine derivatives and process for preparing the same
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/16/2003CA2046429C Imide derivatives, and their production and use
09/16/2003CA2042745C Novel hardenable compositions
09/12/2003WO2003074990A2 Artificial receptors, building blocks, and methods
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 404